Search Within

Viktoriya Paroder

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (8)
Groups
  1. Body Imaging Service (25)
  2. Epidemiology and Biostatistics (25)
  3. Radiology, Department of (25)
  4. Biostatistics Service (22)
  5. Center for Pancreatic Cancer Research (19)
  6. Department of Medicine (15)

More Groups

People
  1. Marinela Capanu (18)
  2. David Bates (11)
  3. Iva Petkovska (9)
  4. Jennifer Golia Pernicka (9)
  5. Joanne Chou (9)
  6. Marc Gollub (9)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (5)
  4. 2022 (5)
  5. 2021 (5)
  6. 2020 (4)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Abdominal Radiology (6)
  3. Journal of Nuclear Medicine (2)
  4. American Journal of Roentgenology (1)
  5. Annals of Oncology (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (8)
  2. Springer (7)
  3. Society of Nuclear Medicine (2)
  4. American Association for Cancer Research (1)
  5. American Association of Physicists in Medicine (1)
  6. American Roentgen Ray Society (1)

More Publishers

Results (25)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identifying baseline rectal MRI features as predictive indicators for local recurrence and metastatic disease in rectal cancer treated with surgical resection and neoadjuvant therapy or surgical resection alone
    Journal Article

    El Homsi, M.; Javed-Tayyab, S.; Charbel, C.; Golia Pernicka, J. S.; Paroder, V.; White, C.; Capanu, M.; Rodriguez, L.; Gangai, N.; Petkovska, I.
    European Journal of Radiology (2025)

    Fulltext@MSK | Save
  • Noninvasive assessment of programmed-death ligand-1 (PD-L1) in esophagogastric (EG) cancer using (18)F-BMS-986229 PET
    Meeting Abstract

    Cytryn, S. L.; Pandit-Taskar, N.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Feder, L.; Philemond, S.; Lyashchenko, S. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • (18)F-BMS-986229 PET to assess programmed-death ligand 1 status in gastroesophageal cancer
    Journal Article

    Cytryn, S. L.; Pandit-Taskar, N.; Lumish, M. A.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Antoine, A.; Loegel, D.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Synoptic reporting for pretreatment CT examination in patients with advanced ovarian cancer: Impact on documentation of disease sites and physician satisfaction
    Journal Article

    Andrieu, P. C.; Nikolovski, I.; Juluru, K.; Sadowski, E.; Gangai, N.; Zheng, J.; Capanu, M.; Praiss, A. M.; Nougaret, S.; Shinagare, A. B.; more...
    American Journal of Roentgenology (2023)

    Fulltext@MSK | Save
  • First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: A single-arm, single-centre, phase 2 trial
    Journal Article

    Cytryn, S. L.; Moy, R. H.; Cowzer, D.; Shah, R. H.; Chou, J. F.; Joshi, S. S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Determinants of survival with combined HER2 and PD-1 blockade in metastatic esophagogastric cancer
    Journal Article

    Maron, S. B.; Chatila, W.; Walch, H.; Chou, J. F.; Ceglia, N.; Ptashkin, R.; Do, R. K. G.; Paroder, V.; Pandit-Taskar, N.; Lewis, J. S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Extramural venous invasion and tumor deposit at diffusion-weighted MRI in patients after neoadjuvant treatment for rectal cancer
    Journal Article

    Kim, T. H.; Firat, C.; Thompson, H. M.; Gangai, N.; Zheng, J.; Capanu, M.; Bates, D. D. B.; Paroder, V.; García-Aguilar, J.; Shia, J.; more...
    Radiology (2023)

    Fulltext@MSK | Save
  • Noninvasive assessment of human epidermal growth factor receptor 2 (HER2) in esophagogastric cancer using (89)Zr-trastuzumab PET: A pilot study
    Journal Article

    Lumish, M. A.; Maron, S. B.; Paroder, V.; Chou, J. F.; Capanu, M.; Philemond, S.; O'Donoghue, J. A.; Schoder, H.; Lewis, J. S.; Lyashchenko, S. K.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Regorafenib (REGO) with nivolumab (NIVO) and FOLFOX in HER2 negative esophagogastric cancer (EGC)
    Meeting Abstract

    Cytryn, S.; Joshi, S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; Rao, D.; Goldberg, Z.; Sugarman, R.; Antoine, A.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • A phase II trial of IDO-inhibitor, BMS-986205 (IDO), and PD-1 inhibitor, nivolumab (NIVO), in recurrent or persistent endometrial cancer (EC; CA017-056)
    Meeting Abstract

    Kyi, C.; Rubinstein, M. M.; Shah, P.; Zhou, Q.; Iasonos, A.; Liu, Y.; Ramirez, L.; Paroder, V.; Green, A.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save